Advertisement
CRISPR Therapeutics Says FDA Grants RMAT Designation To CTX130
(RTTNews) - Biopharmaceutical company CRISPR Therapeutics (CRSP) announced Wednesday that the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to CTX130, the Company's wholly-owned allogeneic CAR T cell therapy targeting CD70, for the treatment of Mycosis Fungoides and Sézary Syndrome (MF/SS).
Established under the 21st Century Cures Act, RMAT designation is a dedicated program designed to expedite the drug development and review processes for promising pipeline products, including genetic therapies.
Similar to Breakthrough Therapy designation, RMAT designation provides the benefits of intensive FDA guidance on efficient drug development.
For More Such Health News, visit rttnews.com
read more
Vertex Pharma Inks Licensing Agreement To Use CRISPR Therapeutics' Gene Editing Technology
Biotechnology company Vertex Pharmaceuticals, Inc. (VRTX) and gene editing company CRISPR Therapeutics, Inc. (CRSP) announced Monday that they have entered into a new non-exclusive licensing agreement for the use of CRISPR Therapeutics' gene editing technology, known as CRISPR/Cas9, to accelerate the development of Vertex's hypoimmune cell therapies for type 1 diabetes (T1D).
RTTNews
|
737 days ago
China Services Activity Growth Accelerates
China's service sector growth accelerated to a three month-high in March on rising business activity and new orders, survey data from S&P Global showed on Thursday. The Caixin services Purchasing Managers' Index logged 51.9 in March compared to 51.4 in February. The index has remained above the crucial 50.0 no-change mark for the twenty-seventh straight month.
RTTNews
|
4h 14min ago
Australian Dollar Falls Against Majors
The Australian dollar weakened against other major currencies in the Asian session on Thursday.
RTTNews
|
4h 40min ago
European Shares Set To Fall As Trump Imposes Sweeping New Tariffs
European stocks are seen opening deep in the red on Thursday after U.S. President Donald Trump announced a 20 percent levies on European goods.
RTTNews
|
4h 40min ago
European Economic News Preview: Eurozone Final Composite PMI Data Due
Final composite Purchasing Managers' survey results from the euro area and the UK are the top economic news due at Thursday. At 3.15 AM ET, S&P Global publishes Spain's services and composite PMI survey data. The services indicator is forecast to fall to 55.6 in March from 56.2 in the previous month. At 3.45 am ET, services and composite PMI data is due from Italy.
RTTNews
|
4h 45min ago
Sensex, Nifty Open Lower; IT And Auto Stocks Drag
Indian shares were slightly lower on Thursday after U.S. President Donald Trump announced 26 percent reciprocal tariff on India - half the rate India imposes on U.S. imports, leaving some room for negotiation.
RTTNews
|
5h 58min ago
Asian Markets Trades Mostly Lower
Asian stock markets are trading mostly lower on Thursday, despite the positive cues from Wall Street overnight, after US President Donald Trump announced steeper-than-expected tariffs on US trade partners, heightening concerns over a global trade war that could destabilize major economies. White House press secretary Karoline Leavitt indicated the new levies will be "effective immediately."
RTTNews
|
6h 49min ago
Australian Market Trims Early Losses In Mid-market
The Australian market is trimming its early losses in mid-market moves on Thursday, giving up the gains in the previous two sessions, despite the broadly positive cues from Wall Street overnight. The benchmark S&P/ASX 200 is falling well below the 7,900 level, with weakness across most sectors led by mining and technology stocks.
RTTNews
|
7h 36min ago
